J. Tay

发表

Minimal residual disease (MRD) assessment by flow cytometry after ASCT for AL amyloidosis: are we there yet?

P. Neri, H. Lee, P. Duggan, 2017, Bone Marrow Transplantation.

A single-institution analysis of the utility of pre-induction ejection fraction measurement in patients newly diagnosed with acute myeloid leukemia

H. Atkins, D. Allan, B. Zanke, 2015, Leukemia & lymphoma.

The Impact of Prolonged Storage of Red Blood Cells on Cancer Survival

D. Allan, A. Tinmouth, R. Mallick, 2013, PloS one.

Storage time of transfused red blood cells and impact on clinical outcomes in hematopoietic stem cell transplantation

D. Allan, S. Doucette, A. Tinmouth, 2011, Transfusion.

Transplantation of umbilical cord blood-derived cells for novel indications in regenerative therapy or immune modulation: a scoping review of clinical studies.

D. Allan, M. Iafolla, J. Tay, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Bortezomib-containing regimens (BCR) for the treatment of non-transplant eligible multiple myeloma

P. Neri, P. Duggan, J. Tay, 2015, Annals of Hematology.

Autologous stem cell transplantation for stiff person syndrome: two cases from the Ottawa blood and marrow transplant program.

H. Atkins, D. Allan, L. Huebsch, 2014, JAMA neurology.

Patient eligibility for hematopoietic stem cell transplantation: a review of patient-associated variables

J. Storek, J. Tay, S. Beattie, 2018, Bone Marrow Transplantation.

Age no bar: A CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma

P. Hari, J. Zaucha, M. Krem, 2020, Cancer.

Revised International Staging System Applied to Real World Multiple Myeloma Patients.

P. Neri, P. Duggan, J. Tay, 2016, Clinical lymphoma, myeloma & leukemia.

Bortezomib Maintenance for the Treatment of Monoclonal Gammopathy of Renal Significance

P. Neri, P. Duggan, J. Tay, 2019, Mediterranean journal of hematology and infectious diseases.

Rationale and design of platelet transfusions in haematopoietic stem cell transplantation: the PATH pilot study

D. Allan, K. Thavorn, D. Fergusson, 2016, BMJ Open.

Protocol for updating a systematic review of randomised controlled trials on the prophylactic use of intravenous immunoglobulin for patients undergoing haematopoietic stem cell transplantation

G. Knoll, J. Tay, D. Cameron, 2015, BMJ Open.

Acquired Factor XIII Inhibitor in Hospitalized and Perioperative Patients: A Systematic Review of Case Reports and Case Series.

M. Lalu, M. Avey, D. Fergusson, 2016, Transfusion medicine reviews.

Outcomes of both abbreviated hyper‐CVAD induction followed by autologous hematopoietic cell transplantation and conventional chemotherapy for mantle cell lymphoma: a 10‐year single‐centre experience with literature review

D. Allan, L. Huebsch, S. Mcdiarmid, 2015, Cancer medicine.

Noninfectious pulmonary complications after hematopoietic stem cell transplantation: practical approach to imaging diagnosis.

D. Allan, C. Dennie, M. Gomes, 2014, Radiographics : a review publication of the Radiological Society of North America, Inc.

Effectiveness and safety of thiotepa as conditioning treatment prior to stem cell transplant in patients with central nervous system lymphoma

D. Fergusson, A. Tinmouth, C. Bredeson, 2014, Leukemia & lymphoma.

Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells.

B. Storer, T. Panzarella, M. Aljurf, 2016, Blood.

Early Relapse after Autologous Hematopoietic Cell Transplantation remains a Poor Prognostic Factor in Multiple Myeloma but Outcomes Have Improved Over Time

A. Krishnan, R. Vij, P. Hari, 2017, Leukemia.

Myasthenia Gravis Treated With Autologous Hematopoietic Stem Cell Transplantation.

H. Atkins, D. Allan, L. Huebsch, 2016, JAMA neurology.

Reduced hemoglobin on day of peripheral blood progenitor cell collection is associated with low graft content of vascular progenitors and increased toxicity after autologous hematopoietic stem cell transplantation

D. Allan, T. Ramsay, L. Huebsch, 2008, Transfusion.

New cancers after autotransplantations for multiple myeloma.

A. Krishnan, S. Lonial, P. Hari, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Post-Transplant Outcomes in High-Risk Compared with Non-High-Risk Multiple Myeloma: A CIBMTR Analysis.

A. Krishnan, P. Hari, R. Kyle, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Early Relapse for Multiple Myeloma Patients Undergoing Single Autologous Stem Cell Therapy: A Single‐center Experience

P. Neri, P. Duggan, J. Tay, 2018, Clinical lymphoma, myeloma & leukemia.

Network geometry of evidence from randomised controlled trials addressing donor selection and source of haematopoietic progenitor cells used in allogeneic transplantation: a systematic scoping review

D. Allan, B. Hutton, C. Bredeson, 2018, Transfusion medicine.

Red cell transfusion thresholds in haematopoietic stem cell transplantation

A. Tinmouth, J. Tay, 2018, ISBT Science Series.

Transfusion of red cells in hematopoietic stem cell transplantation (TRIST): study protocol for a randomized controlled trial

D. Allan, D. Fergusson, A. Tinmouth, 2011, Trials.

Liberal Versus Restrictive Red Blood Cell Transfusion Thresholds in Hematopoietic Cell Transplantation: A Randomized, Open Label, Phase III, Noninferiority Trial.

D. Allan, D. Coyle, D. Fergusson, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation

A. Krishnan, W. Wood, P. Hari, 2015, Bone Marrow Transplantation.

Amyloidosis and COVID-19: experience from an amyloid program in Canada

N. Fine, P. Neri, P. Duggan, 2022, Annals of Hematology.

Observational studies: what is a cohort study?

A. Tinmouth, J. Tay, 2007, Transfusion.

Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the prevention of hepatic veno-occlusive disease in hematopoietic stem cell transplantation.

D. Allan, D. Fergusson, L. Huebsch, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cutaneous plasmacytoma-like posttransplant lymphoproliferative disorder after renal transplantation with response to imiquimod 5% cream and reduced immunosuppression

R. Wong, J. Tay, Pavandeep Gill, 2019, JAAD case reports.

Correction: The Influence of Social Support on Hematopoietic Stem Cell Transplantation Survival: A Systematic Review of Literature

S. Lebel, J. Tay, S. Beattie, 2013, PLoS ONE.

Impact of COVID-19 on the Diagnosis and Management of Multiple Myeloma: Experience from a Canadian Center.

P. Neri, C. Chambers, P. Duggan, 2021, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

Excess of deaths for patients with plasma cell proliferative disorders as a result of the COVID-19 pandemic

T. Dunne, P. Neri, P. Duggan, 2021, Leukemia & lymphoma.

Real-world treatment patterns for patients with newly diagnosed multiple myeloma in Alberta, Canada

J. Tay, V. Jimenez-Zepeda, Guanmin Chen, 2022, Leukemia & lymphoma.

Factors associated with the avoidance of red blood cell transfusion after hematopoietic stem cell transplantation

D. Allan, A. Tinmouth, R. Mallick, 2012, Transfusion.

A plerixafor-based strategy allows adequate hematopoietic stem cell collection in poor mobilizers: results from the Canadian Special Access Program

D. Allan, L. Huebsch, C. Bredeson, 2014, Bone Marrow Transplantation.

Systematic review of randomized controlled trials of hematopoietic stem cell mobilization strategies for autologous transplantation for hematologic malignancies.

D. Allan, C. Bredeson, J. Tay, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The Use of Intravenous Antibiotics at the Onset of Neutropenia in Patients Receiving Outpatient-Based Hematopoietic Stem Cell Transplants

L. Huebsch, S. Mcdiarmid, C. Bredeson, 2012, PloS one.

Predictors of lost to follow-up among pediatric and adult hematopoietic cell transplant survivors: A report from the Center for International Blood and Marrow Transplant Research.

W. Wood, M. Aljurf, A. Yoshimi, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor selection for patients undergoing allogeneic hematopoietic stem cell transplantation: Assessment of the priorities of Canadian hematopoietic stem cell transplant physicians

J. Tay, 2009 .

High incidence of Pneumocystis jirovecii pneumonia in allogeneic hematopoietic cell transplant recipients in the modern era.

J. Storek, P. Duggan, J. Tay, 2019, Cytotherapy.

Clinical outcomes of polyvalent immunoglobulin use in solid organ transplant recipients: A systematic review and meta‐analysis – Part II: Non‐kidney transplant

B. Hutton, G. Knoll, J. Tay, 2019, Clinical transplantation.

Clinical outcomes of polyvalent immunoglobulin use in solid organ transplant recipients: A systematic review and meta‐analysis

B. Hutton, G. Knoll, J. Tay, 2019, Clinical transplantation.

Effectiveness of immunoglobulin prophylaxis in reducing clinical complications of hematopoietic stem cell transplantation: a systematic review and meta‐analysis

B. Hutton, B. Shea, J. Tay, 2018, Transfusion.

Zoster prophylaxis after allogeneic hematopoietic cell transplantation using acyclovir/valacyclovir followed by vaccination.

J. Storek, P. Duggan, J. Tay, 2016, Blood advances.

A Systematic Review of Preclinical Studies on the Therapeutic Potential of Mesenchymal Stromal Cell-Derived Microvesicles

R. B. Richardson, D. Allan, D. Fergusson, 2015, Stem Cell Reviews and Reports.

Optimal transfusion practices after allogeneic hematopoietic cell transplantation: a systematic scoping review of evidence from randomized controlled trials

D. Allan, A. Tinmouth, C. Bredeson, 2016, Transfusion.

Impact of platelet transfusion on toxicity and mortality after hematopoietic progenitor cell transplantation

H. Atkins, D. Allan, L. Huebsch, 2015, Transfusion.

Older patients with myeloma derive similar benefit from autologous transplantation.

A. Krishnan, S. Lonial, P. Hari, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Major ABO-incompatible BMT: isohemagglutinin reduction with plasma exchange is safe and avoids graft manipulation

L. Huebsch, S. Mcdiarmid, C. Bredeson, 2013, Bone Marrow Transplantation.

Thymoglobulin Decreases the Need for Immunosuppression at 12 Months after Myeloablative and Nonmyeloablative Unrelated Donor Transplantation: CBMTG 0801, a Randomized, Controlled Trial

T. Panzarella, G. Devins, Stephanie J. Lee, 2014 .

The impact of COVID‐19 in the management of AL amyloidosis and Immunoglobulin Deposition Disease: A single‐center experience

P. Neri, P. Duggan, J. Tay, 2020, European journal of haematology.

Long-term graft function following autologous hematopoietic cell transplantation and the impact of preemptive plerixafor in predicted poor mobilizers

D. Allan, L. Huebsch, S. Mcdiarmid, 2018, Blood Cancer Journal.

Transfusion of Red Cells in Hematopoietic Stem Cell Transplantation (TRIST Study): A Randomized Controlled Trial Evaluating 2 Red Cell Transfusion Thresholds

D. Allan, D. Coyle, D. Fergusson, 2016 .

Current trends in clinical studies of allogeneic hematopoietic stem cell transplantation.

D. Allan, C. Bredeson, J. Tay, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Salvage second hematopoietic cell transplantation in myeloma.

J. Vose, A. Krishnan, S. Lonial, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Is cytomegalovirus testing of blood products still needed for hematopoietic stem cell transplant recipients in the era of universal leukoreduction?

D. Allan, L. Huebsch, S. Mcdiarmid, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Canadian cost analysis comparing maintenance therapy with bortezomib versus lenalidomide for patients with multiple myeloma post autologous stem cell transplant.

R. LeBlanc, J. Tay, S. Hollmann, 2016, Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharamcologie clinique.

Incidence and predictive factors of symptomatic thrombosis related to peripherally inserted central catheters in chemotherapy patients.

Marc Carrier, Andrew Aw, S. Mcdiarmid, 2012, Thrombosis research.

Utility of comorbidity assessment in predicting transplantation-related toxicity following autologous hematopoietic stem cell transplantation for multiple myeloma.

H. Atkins, D. Allan, L. Huebsch, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pre-transplant marital status and hematopoietic cell transplantation outcomes.

W. Wood, K. Sullivan, M. Aljurf, 2020, Current oncology.

Erythematous eruption in a man with acute myeloid leukemia.

J. Tay, 2002, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Real-world outcomes with cumulative bortezomib dose and efficacy in the treatment of transplant-ineligible multiple myeloma with cyclophosphamide, bortezomib, and dexamethasone

P. Neri, P. Duggan, J. Tay, 2022, Clinical Lymphoma Myeloma and Leukemia.

Immunoparesis and polyclonal immunoglobulin recovery after auto-SCT for patients with multiple myeloma treated at a single institution

P. Neri, P. Duggan, J. Tay, 2018, Leukemia & lymphoma.

Improved Prediction of CD34+ Cell Yield before Peripheral Blood Hematopoietic Progenitor Cell Collection Using a Modified Target Value-Tailored Approach.

D. Allan, L. Huebsch, S. Mcdiarmid, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

M. Norkin, R. Vij, F. Buadi, 2018, Leukemia & lymphoma.

High-Risk Cytogenetics Multiple Myeloma: Impact of Consolidation and Maintenance

P. Neri, P. Duggan, J. Tay, 2016 .

Suboptimal response for AL amyloidosis: is it time for early switch? Experience from a single amyloid program

P. Neri, P. Duggan, J. Tay, 2022, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) for the Treatment of Newly Diagnosed AL Amyloidosis: Impact of Response on Survival Outcomes.

P. Neri, J. Luider, P. Duggan, 2019, Clinical lymphoma, myeloma & leukemia.

Donor selection for patients undergoing allogeneic hematopoietic SCT: assessment of the priorities of Canadian hematopoietic SCT physicians

D. Allan, D. Coyle, A. Tinmouth, 2013, Bone Marrow Transplantation.

N-Terminal pro-brain natriuretic peptide (NTproBNP) in patients with symptomatic multiple myeloma: report from a single institution

P. Neri, P. Duggan, J. Tay, 2021, Annals of Hematology.

Cyclophosphamide, Bortezomib and Methylprednisolone (CyBorMe) for the Treatment of AL Amyloidosis: Initial Experience From a Single Center

N. Fine, P. Neri, P. Duggan, 2021, Indian Journal of Hematology and Blood Transfusion.

The Influence of Social Support on Hematopoietic Stem Cell Transplantation Survival: A Systematic Review of Literature

S. Lebel, J. Tay, S. Beattie, 2013, PloS one.

Slow lenalidomide desensitization protocol for patients with multiple myeloma: case series from a single center

P. Neri, P. Duggan, J. Tay, 2019, Leukemia & lymphoma.

Identification of Specificity Groups in Myeloma Patients T Cell Receptor (TCR) Repertoire through Single Cell TCR Sequencing

P. Neri, P. Duggan, J. Tay, 2018, Blood.

Immunome Single Cell Profiling Reveals T Cell Exhaustion with Upregulation of Checkpoint Inhibitors LAG3 and Tigit on Marrow Infiltrating T Lymphocytes in Daratumumab and IMiDs Resistant Patients

P. Neri, P. Duggan, J. Tay, 2018, Blood.

Single Cell Resolution Profiling Defines the Innate and Adaptive Immune Repertoires Modulated By Daratumumab and IMiDs Treatment in Multiple Myeloma (MM)

P. Neri, L. Boise, P. Duggan, 2017 .

Minimal Residual Disease (MRD) Assessed By Flow Cytometry in Patients with AL Amyloidosis Treated with Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD)

P. Neri, P. Duggan, J. Tay, 2017 .

Evaluation of an Outpatient Model for Treatment of Acute Myeloid Leukemia

H. Atkins, D. Allan, T. Ramsay, 2016 .

Thromboprophylaxis In Multiple Myeloma Patients Undergoing Immunomodulatory Therapy with Thalidomide and Lenalidomide: A Systematic Review and Meta-Analysis.

G. Gal, Agnes Y. Y. Lee, J. Tay, 2010 .

Monoclonal Gammopathy of Undetermined Significance in Patients With Transthyretin Amyloidosis (ATTR): Analysis Using the iStopMM Criteria.

N. Fine, Ellen Lewis, J. Tay, 2022, Clinical lymphoma, myeloma & leukemia.

Ectopic ascariasis: report of a case with adult worms in the kidney.

J. Tay, A. Martuscelli, J. Bustamante-Sarabia, 1977, The American journal of tropical medicine and hygiene.

Serial assessment of toxicity after hematopoietic SCT can discern kinetics of transplant-related organ injury and patterns of recovery

H. Atkins, D. Allan, L. Huebsch, 2012, Bone Marrow Transplantation.

A Canadian Cost Impact Analysis Comparing Maintenance Therapy with Bortezomib Versus Lenalidomide in Multiple Myeloma Patients Ineligible for Stem Cell Transplant

R. LeBlanc, J. Tay, S. Hollmann, 2014 .

A national survey of screening and management of hypogammaglobulinemia in Canadian transplantation centers

G. Knoll, C. Bredeson, J. Tay, 2017, Transplant infectious disease : an official journal of the Transplantation Society.

Early mortality following diagnosis of multiple myeloma from 2011 to 2016 in Alberta, Canada: Initial results from the population-based Identifying Outcomes in Real-World Multiple Myeloma (INFORMM) study.

J. Tay, V. Jimenez-Zepeda, Guanmin Chen, 2019, Journal of Clinical Oncology.

Impact of ethnicity on human umbilical cord blood banking: a systematic review

D. Allan, J. Tay, H. Elmoazzen, 2014, Transfusion.

Long-term graft function following autologous hematopoietic cell transplantation and the impact of preemptive plerixafor in predicted poor mobilizers

D. Allan, L. Huebsch, S. Mcdiarmid, 2018, Blood Cancer Journal.

Rates of venous thromboembolism in multiple myeloma patients undergoing immunomodulatory therapy with thalidomide or lenalidomide: a systematic review and meta‐analysis

G. Gal, J. Tay, G. Le Gal, 2011, Journal of thrombosis and haemostasis : JTH.

Balancing give and take between patients and their spousal caregivers in hematopoietic stem cell transplantation

K. Wilson, G. Devins, Cheryl Harris, 2017, Psycho-oncology.

Thromboprophylaxis for catheter‐related thrombosis in patients with cancer: a systematic review of the randomized, controlled trials

P. Wells, D. Fergusson, J. Tay, 2007, Journal of thrombosis and haemostasis : JTH.

Treatment response measurements and survival outcomes in a cohort of newly diagnosed AL amyloidosis

P. Neri, P. Duggan, J. Tay, 2021, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Transfusion of red cells in hematopoietic stem cell transplantation (TRIST): study protocol for a randomized controlled trial

D. Allan, D. Fergusson, A. Tinmouth, 2011, Trials.

Clinical outcomes of immunoglobulin use in solid organ transplant recipients: protocol for a systematic review and meta-analysis

B. Hutton, G. Knoll, J. Tay, 2015, Systematic Reviews.

Anti‐myeloma potential of ruxolitinib in co‐existing JAK2V617F‐positive smouldering myeloma and polycythaemia vera

P. Neri, P. Duggan, J. Tay, 2020, British journal of haematology.

A Systematic Review of Preclinical Studies on the Therapeutic Potential of Mesenchymal Stromal Cell-Derived Microvesicles

R. B. Richardson, Dean Fergusson, D. Allan, 2014, Stem Cell Reviews and Reports.

Rates of venous thromboembolism in multiple myeloma patients undergoing immunomodulatory therapy with thalidomide or lenalidomide: a systematic review and meta‐analysis

G. Gal, Agnes Y. Y. Lee, J. Tay, 2011, Journal of thrombosis and haemostasis : JTH.

Effect of the Presence of t(11;14) for Patients With AL Amyloidosis Treated With Bortezomib-Containing Regimens: Experience From the Amyloidosis Program of Calgary.

P. Neri, Ellen Lewis, P. Duggan, 2023, Clinical lymphoma, myeloma & leukemia.

Importance of factors influencing the decision to proceed with cord blood transplantation in adults: results of a web-based survey of the Canadian transplant community

D. Allan, J. Tay, J. Chan, 2013, Bone Marrow Transplantation.